Intercure

Business Overview

InterCure (Canndoc Pharma) is the first and only public company on the Tel Aviv Stock Exchange (TASE: INCR), which holds a valid and permanent license for the entire medical cannabis value chain. The company has recently acquired full ownership and control (100%) of Canndoc Pharma. Canndoc is a leading pioneer in the medical cannabis sector in Israel and worldwide, and has been in engaged in ten years of research, nurturing, cultivating and marketing medical cannabis to thousands of patients with a range of indications that have been approved by Israel’s Ministry of Health and collaborate with partners in Israel and abroad. Visit https://www.canndoc.co.il

In addition, InterCure holds a 17.25% stake in Regenera, a clinical-stage biopharmaceutical company focused on developing a novel drug for neurological disorders. Visit https://www.regenerapharma.com/

InterCure also holds a 9.3% stake in Novellus, a Jerusalem based company, developing a novel technology for precision oncology therapies. Visit www.novellusdx.com.

Investor type
Company

Team

Intercure
Ehud Barak
Chairman

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

NovellusDX
Active
Software
B2B
$80 M
2

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

Similar Investors

Picus Capital
TYPE
Venture Capital
Chartered Group
TYPE
Private Equity
TheTime
TYPE
Venture Capital
Sweetwood Capital
TYPE
Venture Capital
Coughdrop Capital
TYPE
Venture Capital
MIN CHEQUE
$0.025 M
Alstom
TYPE
Company
Vitruvian Partners
TYPE
Venture Capital
MIN CHEQUE
$35 M
Graph Ventures
TYPE
Venture Capital
The Unofficial Syndicate
TYPE
Angel Syndicate
Chicago Ventures
TYPE
Venture Capital
Viola Growth
TYPE
Venture Capital
MIN CHEQUE
$15 M
Glory Ventures
TYPE
Venture Capital
Genesis Partners
TYPE
Venture Capital
Nielsen Innovate
TYPE
Corporate Venture Capital
MIN CHEQUE
$0.58 M
Power Capital Ventures
TYPE
Venture Capital
83North
TYPE
Venture Capital
MIN CHEQUE
$1 M
Sapphire Ventures
TYPE
Venture Capital
MIN CHEQUE
$10 M
Menomadin Foundation
TYPE
Foundation
Claltech
TYPE
Corporate Venture Capital
Georgian Partners
TYPE
Venture Capital
MIN CHEQUE
$5 M

CONTACT

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month